Revenue

A new framework signals a major shift from message control to radical transparency. Here's why brands that embrace authenticity will win in a skeptical market.

An $8.75 billion merger was meant to create a building giant. Instead, a 35% stock crash has sparked a securities investigation into James Hardie.

A new drug targeting a genetic form of Parkinson's shows promise as its late-stage trial nears completion, offering hope for a precision treatment.

The Don Pepino owner is buying the organic tomato brand from General Mills, a strategic move set to reshape the competitive $5 billion tomato products aisle.

A new report reveals U.S. restaurants are overcoming financial strain, shedding debt, and hitting double-digit profit margins by embracing technology.

BioTalent Canada's latest awards highlight how inclusivity, diversity, and equity are becoming key drivers of innovation and profit in the bioscience sector.

New research provides the strongest human evidence that sleep actively clears toxic proteins linked to Alzheimer's, opening a new frontier for prevention.

Libraesva and Cyber Guru combine to tackle the human element in cybersecurity, aiming to create a European leader against US giants in a growing market.

A strategic partnership between MEXC Ventures and local giant TRIV signals a new era for crypto in Indonesia, blending global tech with a decade of local trust.

A Norwegian firm's new AI software aims to reduce physician distractions and build trust, setting a new standard for cancer-detecting technology.

A new report reveals 84% of high-risk firms are unprepared for insider threats as state actors increasingly target the human factor within organizations.

China approves Libevitug, a first-in-class drug for the most severe form of hepatitis, marking a major milestone for patients and global biotech innovation.

With drug pipelines facing staggering failure rates, HKeyBio's new preclinical strategy aims to de-risk R&D and accelerate effective new treatments.

Hong Kong's first CSI A500 ETF is set to launch, offering a new, diversified way for global investors to tap into 500 of China's leading A-shares.

A Dubai-based PR firm leverages Web Summit Qatar to challenge industry giants, blending SEO with traditional newswire for the AI and Web3 era.

Activist investor Farallon Capital pressures insurer T&D Holdings with a public blueprint for reform, demanding bold changes ahead of its 2026 vision.

3Shape appoints Coloplast's Rasmus Hannemann as SVP, a strategic move signaling a major push to accelerate growth in the competitive digital dentistry market.

Roche's CT-388 posts impressive Phase II results, positioning it as a powerful new rival to Zepbound and Wegovy in the booming obesity drug market.

A stunning New Year's show with 500 drones and fireworks at a luxury hotel signals a new era of high-tech, experiential tourism in Japan.

With David McClelland at the helm, Santander US Auto aims to leverage deep OEM ties and a novel digital banking strategy to navigate a shifting market.